MBIO MUSTANG BIO INC revenue, earnings and financials
For the quarter ended June 30, 2026, MUSTANG BIO INC reported revenue of n/a, net income of −$1.07M and diluted EPS of −$0.16; for the fiscal year ended December 2025 revenue was n/a.
MBIO annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$2.43M, net income −$1.92M (margin n/a), EPS −$0.39
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$16.2M, net income −$15.8M (margin n/a), EPS −$38.57
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$49.3M, net income −$51.6M (margin n/a), EPS −$299.95
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$76.2M, net income −$77.5M (margin n/a), EPS −$10.09
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$66.7M, net income −$66.4M (margin n/a), EPS −$0.76
MBIO quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$1.07M, EPS −$0.16
- Quarter ended Mar 31, 2026: revenue n/a, net income −$955K, EPS −$0.14
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$538K, EPS −$0.08
- Quarter ended Sep 30, 2025: revenue n/a, net income −$468K, EPS −$0.07
- Quarter ended Jun 30, 2025: revenue n/a, net income −$762K, EPS −$0.19
- Quarter ended Mar 31, 2025: revenue n/a, net income −$153K, EPS −$0.05
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$952K, EPS $6.56
- Quarter ended Sep 30, 2024: revenue n/a, net income −$1.41M, EPS −$1.96
- Quarter ended Jun 30, 2024: revenue n/a, net income −$8.20M, EPS −$18.36
- Quarter ended Mar 31, 2024: revenue n/a, net income −$5.19M, EPS −$24.81
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$8.62M, EPS −$294.66
- Quarter ended Sep 30, 2023: revenue n/a, net income −$10.1M, EPS −$1.23
- Quarter ended Jun 30, 2023: revenue n/a, net income −$16.2M, EPS −$2.00
- Quarter ended Mar 31, 2023: revenue n/a, net income −$16.7M, EPS −$2.06
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$19.6M, EPS −$2.46
- Quarter ended Sep 30, 2022: revenue n/a, net income −$19.0M, EPS −$2.42
- Quarter ended Jun 30, 2022: revenue n/a, net income −$19.1M, EPS −$2.50
- Quarter ended Mar 31, 2022: revenue n/a, net income −$19.8M, EPS −$2.71
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$20.0M, EPS −$0.22
- Quarter ended Sep 30, 2021: revenue n/a, net income −$17.0M, EPS −$0.19
MBIO cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$5.26M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$11.4M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$49.5M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$65.1M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$53.7M, share buybacks n/a
MBIO balance sheet
- Jun 30, 2026: cash $15.2M, total assets $15.6M, total liabilities $8.07M, shareholders' equity $7.55M
- Mar 31, 2026: cash $16.3M, total assets $16.6M, total liabilities $7.99M, shareholders' equity $8.60M
- Dec 31, 2025: cash $17.3M, total assets $17.6M, total liabilities $8.06M, shareholders' equity $9.53M
- Sep 30, 2025: cash $19.0M, total assets $19.4M, total liabilities $9.59M, shareholders' equity $9.77M
- Jun 30, 2025: cash $12.7M, total assets $13.0M, total liabilities $10.2M, shareholders' equity $2.89M
- Mar 31, 2025: cash $14.2M, total assets $14.9M, total liabilities $11.3M, shareholders' equity $3.61M
- Dec 31, 2024: cash $6.84M, total assets $9.31M, total liabilities $13.2M, shareholders' equity −$3.87M
- Sep 30, 2024: cash $3.53M, total assets $7.19M, total liabilities $15.8M, shareholders' equity −$8.66M
Is MBIO profitable?
No. MUSTANG BIO INC lost $3.03M over the last four quarters.
What is MBIO's EPS?
Diluted earnings per share over the last four quarters were −$0.45; −$0.16 in the latest quarter.